Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial
Conclusion:
The results of this study will provide solid evidence for determining the optimal treatment regimen for first-line H pylori eradication in Korea.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Clinical Trial Source Type: research
More News: Amoxicillin | Biaxin | Clarithromycin | Clinical Trials | Genetics | Helicobacter Pylori | Internal Medicine | Metronidazole | Proton Pump Inhibitors PPIs | Study | Tetracycline